ANTIDEPRESSANTSKAISER C; BONDINELL WE.1981; ANNU. REP. MED. CHEM.; ISSN 0065-7743; USA; DA. 1981; VOL. 16; PP. 1-10; BIBL. 160 REF.Article

CARCINOGENICITY OF METHYLCHRYSENES = CANCEROGENICITE DES METHYLCHRYSENESHOFFMANN D; BONDINELL WE; WYNDER EL et al.1974; SCIENCE; U.S.A.; DA. 1974; VOL. 183; NO 4121; PP. 215-216; BIBL. 5REF.Article

CHRYSENE AND METHYLCHRYSENES: PRESENCE IN TOBACCO SMOKE AND CARCINOGENICITY = CHRYSENE ET METHYLCHRYSENES: PRESENCE DANS LA FUMEE DE TABAC ET CANCERIGENICITEHECHT SS; BONDINELL WE; HOFFMANN D et al.1974; J. NATION. CANCER INST.; U.S.A.; DA. 1974; VOL. 53; NO 4; PP. 1121-1133; BIBL. 37REF.Article

SYNTHESIS OF 2-HYDROXYQUINIC AND 2-HYDROXYEPIQUINIC ACIDS FROM SHIKIMIC ACIDADLERSBERG M; BONDINELL WE; SPRINSON DB et al.1973; J. AMER. CHEM. SOC.; U.S.A.; DA. 1973; VOL. 95; NO 3; PP. 887-896; BIBL. 33 REF.Serial Issue

STEREOCHEMICAL STUDIES OF THE PYRUVATE KINASE REACTION WITH (Z)- AND (E)-PHOSPHOENOL-ALPHA -KETOBUTYRATE.ADLERSBERG M; DAYAN J; BONDINELL WE et al.1977; BIOCHEMISTRY; U.S.A.; DA. 1977; VOL. 16; NO 20; PP. 4382-4387; BIBL. 37 REF.Article

NEW SYNTHESIS OF SOME ARYLTHIO-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINESKU TW; MCCARTHY ME; BONDINELL WE et al.1982; J. ORG. CHEM.; ISSN 0022-3263; USA; DA. 1982; VOL. 47; NO 20; PP. 3862-3865; BIBL. 12 REF.Article

α- and β-adrenoceptors : from the gene to the clinic. II: Structure-activity relationships and therapeutic applicationsRUFFOLO, R. R; BONDINELL, W; HIEBLE, J. P et al.Journal of medicinal chemistry (Print). 1995, Vol 38, Num 19, pp 3681-3716, issn 0022-2623Article

α- and β-adrenoceptors : from the gene to the clinic. I: Molecular biology and adrenoceptor subclassificationHIEBLE, J. P; BONDINELL, W. E; RUFFOLO, R. R et al.Journal of medicinal chemistry (Print). 1995, Vol 38, Num 18, pp 3415-3444, issn 0022-2623Article

INHIBITORS OF PHENYLETHANOLAMINE N-METHYLTRANSFERASE AND EPINEPHRINE BIOSYNTHESIS. I: CHLORO-SUBSTITUTED 1,2,3,4-TETRAHYDROISOQUINOLINESBONDINELL WE; CHAPIN FW; GIRARD GR et al.1980; J. MEDICIN. CHEM.; USA; DA. 1980; VOL. 23; NO 5; PP. 506-511; BIBL. 62 REF.Article

6-(PHENYLTHIO)-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES, A NOVEL CLASS OF DOPAMINE RECEPTOR ANTAGONISTS AND NEUROLEPTICSKAISER C; ALI FE; BONDINELL WE et al.1980; J. MED. CHEM.; ISSN 0022-2623; USA; DA. 1980; VOL. 23; NO 9; PP. 975-976; BIBL. 27 REF.Article

Anticonvulsant profiles of the potent and orally active GABA uptake inhibitors SK&F 89976-A and SK-F 100330-A and four prototype antiepileptic drugs in mice and ratsSWYINYARD, E. A; STEVE WHITE, H; WOLF, H. H et al.Epilepsia (Copenhagen). 1991, Vol 32, Num 4, pp 569-577, issn 0013-9580Article

STUDIES ON SK & F 29661, AN ORGAN-SPECIFIC INHIBITOR OF PHENYLETHANOLAMINE N-METHYLTRANSFERASEPENDLETON RG; GESSNER G; WEINER G et al.1979; J. PHARMARCOL. EXPER. THERAPEUT.; USA; DA. 1979; VOL. 208; NO 1; PP. 24-30; BIBL. 15 REF.Article

Cholecstokinin stimulates neuronal receptors to produce contraction of the canine colonBARONE, F. C; BONDINELL, W. E; LABOSH, T. J et al.Life sciences (1973). 1989, Vol 44, Num 8, pp 533-542, issn 0024-3205Article

Tetrahydrothiadiazoloisoquinolines: synthesis and inhibition of phenylethanolamine-N-methyltransferaseGIRARD, G. R; BONDINELL, W. E; HILLEGASS, L. M et al.Journal of medicinal chemistry (Print). 1989, Vol 32, Num 7, pp 1566-1571, issn 0022-2623Article

Potent non-peptide fibrinogen receptor antagonists which present an alternative pharmacophoreKU, T. W; MILLER, W. H; BONDINELL, W. F et al.Journal of medicinal chemistry (Print). 1995, Vol 38, Num 1, pp 9-12, issn 0022-2623Article

Orally bioavailable nonpeptide vitronectin receptor antagonists containing 2-aminopyridine arginine mimeticsKEENAN, R. M; MILLER, W. H; SMITH, B. R et al.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 13, pp 1801-1806, issn 0960-894XArticle

Azepanone-based inhibitors of human cathepsin S: Optimization of selectivity via the P2 substituentKERNS, Jeffrey K; HONG NIE; XIAOYANG DONG et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 15, pp 4409-4415, issn 0960-894X, 7 p.Article

The use of rabbit intestinal permeability as an in vitro assay in the search for orally active GPIIb/IIIa antagonistsSAMANEN, J. M; LEE, C.-P; NICHOLS, A. J et al.Advanced drug delivery reviews. 1997, Vol 23, Num 1-3, pp 133-142, issn 0169-409XArticle

Synthesis and LTD₄-antagonist activity of desamino-2-nor-leukotriene analogsPERCHONOCK, C. D; UZINSKAS, I; TUCKER, S. S et al.Prostaglandins. 1985, Vol 29, Num 1, pp 75-81, issn 0090-6980Article

Orally active and potent inhibitors of γ-aminobutyric acid uptakeALI, F. E; BONDINELL, W. E; HYE-JA OH et al.Journal of medicinal chemistry (Print). 1985, Vol 28, Num 5, pp 653-660, issn 0022-2623Article

Preclinical pharmacokinetics and interspecies scaling of a novel vitronectin receptor antagonistWARD, K. W; AZZARANO, L. M; MUMAW, J. A et al.Drug metabolism and disposition. 1999, Vol 27, Num 11, pp 1232-1241, issn 0090-9556Article

Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (αvβ3) antagonistsKEENAN, R. M; MILLER, W. H; KU, T. W et al.Bioorganic & medicinal chemistry letters (Print). 1998, Vol 8, Num 22, pp 3165-3170, issn 0960-894XArticle

Conformational preferences in a benzodiazepine series of potent nonpeptide fibrinogen receptor antagonistsKEENAN, R. M; CALLAHAN, J. F; JAKAS, D. R et al.Journal of medicinal chemistry (Print). 1999, Vol 42, Num 4, pp 545-559, issn 0022-2623Article

Direct design of a potent non-peptide fibrinogen receptor antagonist based on the structure and conformation of a highly constrained cyclic RGD peptideKU, T. W; ALI, F. E; GLEASON, J. G et al.Journal of the American Chemical Society. 1993, Vol 115, Num 19, pp 8861-8862, issn 0002-7863Article

Potent, selective, orally active 3-oxo-1,4-benzodiazepine GPIIb/IIIa integrin antagonistsSAMANEN, J. M; ALI, F. E; FEUERSTEIN, G et al.Journal of medicinal chemistry (Print). 1996, Vol 39, Num 25, pp 4867-4870, issn 0022-2623Article